您的购物车当前为空
PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respective IC50: 0.88 and 23 nM). PF-03715455 has the potential for the treatment of COPD.

PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respective IC50: 0.88 and 23 nM). PF-03715455 has the potential for the treatment of COPD.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 19,400 | 3-6月 | |
| 50 mg | ¥ 25,800 | 3-6月 | |
| 100 mg | ¥ 33,500 | 3-6月 |
PF-03715455 相关产品
| 产品描述 | PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respective IC50: 0.88 and 23 nM). PF-03715455 has the potential for the treatment of COPD. |
| 靶点活性 | p38β:23 nM, p38α:0.88 nM |
| 体外活性 | PF-03715455 is a moderate inhibitor of CYP1A2, CYP2C19, and CYP2D6. It also is an effective inhibitor of CYP's 2C9 and CYP3A4[2]. |
| 体内活性 | PF-03715455 treatment displays that the Vss is 0.19 L/kg and T1/2 is 1 hour [2]. |
| 分子量 | 700.27 |
| 分子式 | C35H34ClN7O3S2 |
| CAS No. | 1056164-52-3 |
| 密度 | 1.39 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容